Your Search Returned 14 tagged news reports
New Delhi, January 22, 2013 Drug firm Lupin on Tuesday said it has received final approval from the US health regulator to sell its generic oral contraceptive Levonorgestrel and Ethinyl Estradiol tablets in the American market. Levonorgestrel and
Drug-maker Lupin Tuesday said its subsidiary Lupin Pharmaceuticals Inc has launched cholesterol lowering drug Fenofibrate tablets in 48mg and 145mg strengths in the United States. The Mumbai-based company's Fenofibrate tablets are a generic version
Pharma major, Lupin Ltd. announced today that its subsidiary Lupin Pharmaceuticals Inc. has received approval for its Norgestimate and Ethinyl Estradiol Tablets, 0.18 mg/0.025 mg,0.215 mg/0.025 mg and 0.25 mg/0.025 mg from the United States Food and
Drug maker Lupin on Tuesday said it has received approval from the US health regulator to market its generic Suprax capsules, used for treating bacterial infections, in the American market. Suprax (Cefixime) capsules in the strength of 400 mg, Lupin
Lupin has acquired an injectables company called I'rom Pharmaceuticals in Japan. The company's Japanese subsidiary, Kyowa, entered into an agreement with I'rom Holdings, a healthcare provider, to acquire 100% outstanding shares of its subsidiary I'
Pharma company Lupin is looking at strengthening its presence in the Japanese market, which is offering great promise to generic drug makers. Vinita Gupta, group president and CEO, Lupin Pharmaceuticals Inc, said the firm will look to continue
NOR-QD (norethindrone tablets) is a progestin-only oral contraceptive indicated for the prevention of pregnancy. "The combined annual sales for the generic are estimated around $52 million for the twelve months ended June 2011, based on IMS Health
In fact, she is quite the drug lord, posting sales of $483 million in 2010-11...We are talking about Lupin Pharmaceuticals Inc, US, of which 43-year-old Gupta is the CEO. Baltimore, Maryland-based Gupta took over Lupin's US business in 1992, after
Best Overall Generic Product Manufacturer among those companies with sales of up to USD 100 million in the Healthcare distribution market. Distributor members to recognize companies that foster strong trading partner relationships with the
Pharma major Lupin today announced that its US subsidiary, Lupin Pharmaceuticals Inc (LPI) has received tentative approval from the US Food and Drug Administration for its metformin hydrochloride extended-release tablets of 500mg and 1000mg strengths.